The recombinant Escherichia coli-derived protease-domain of tissue-type plasminogen activator is a potent and fibrin specific fibrinolytic agent

Fibrinolysis

Volumn 10, Issue 2, 1996, Pages 93-102

  Kohnert, U ^a   Hellerbrand, K ^a   Martin, U ^a   Stern, A ^a   Popp, F ^a   Fischer, S ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRIN;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0029971782     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80084-1     Document Type: Article

References (24)

1. Verheijen J H, Caspers M P M, Chang G T G, de Munk G A W, Pouwels P H, Enger-Valk B E. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin. EMBO J 1986; 5 : 3525-3530.
2. Dodd I, Fears R, Robinson J H. Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator. Thromb Haemostas 1986; 55: 94-97.
3. Rijken D C, Groeneveld E. Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator. J Biol Chem 1986; 261: 3098-3102.
4. MacDonald M E, van Zonneveld A-J, Pannekoek H. Functional analysis of the human tissue-type plasminogen activator protein: the light chain. Gene 1986; 42: 59-67.
5. Gething M J, Adler B, Boose J-A et al. Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J 1988; 7: 2731-2740.
6. Martin U, Kohnert U, Hellerbrand K et al. Effective thrombolysis by a recombinant Escherichia coli produced protease domain of tissue-type plasminogen activator in the rabbit model of jugular vein thrombosis. Fibrinolysis 1996; 10: 00-00.
7. Joubert F J. Purification and properties of the proteinase inhibitors from Erythrina caffra (coast Erythrina) seed. Int J Biochem 1982; 14: 187-193.
8. Pannekoek H, Lijnen H R, Loskutoff D J. Recommendations for the nomenclature of mutant fibrinolytic genes and their proteins. Thromb Haemostas 1990; 64: 600-603.
9. Maniatis T, Frisch E F, Sambrook T. In: Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
10. Brinkmann U, Mattes R, Buckel P. High level expression of recombinant genes in E. coli is dependent on the availability of dnaY gene product. Gene 1989; 85: 109-114.
11. Kohnert U, Rudolph R, Verheijen J H et al. Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng 1992; 5: 93-100.
12. Heussen C, Joubert F, Dowdle E B. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor. J Biol Chem 1984; 259: 11635-11638.
13. Kruithof E K O, Schleuning W-D, Bachmann F. Human tissue-type plasminogen activator. Biochem J 1985; 226: 631-636.
14. Verheijen J H, Mullaart E, Chang G T G, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48: 266-269.
15. Beebe D P, Wood L L. A collaborative study to establish a US reference for tissue plasminogen activator (t-PA). Biologicals 1991; 19: 229-232.
16. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246.
17. Rijken D C, Hoylaerts M, Collen D. Fibrinolylic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem 1982; 257: 2920-2925.
18. Hoylaerts M, Rijken D C, Lijnen H R, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem 1982; 257: 2912-2919.
19. Sobel B E, Nachowiak D A, Fry ETA, Bergmann S R, Torr S R. Paradoxial attenuation of fibrinolysis attributable to 'plasminogen steal' and its implication for coronary thrombolysis. Coronary Artery Disease 1990; 1: 111-119.
20. de Vries C, Veeerman H, Koorneef E, Pannekoek H. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin. J Biol Chem 1990; 265: 13547-13552.
21. Sabovic M, Lijnen H R, Keber D, Collen D. Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis. Thromb Haemost 1990; 64: 450-454.
22. Kohnert U, Horsch B, Fischer S. A variant of tissue plasminogen activator (t-PA) comprised of the kringle 2 and the protease domain shows a significant difference in the in vitro rate of plasmin formation as compared to the recombinant human t-PA from transformed Chinese hamster ovary cells. Fibrinolysis 1993; 7: 365-372.
23. Martin U, Fischer S, Kohnert U et al. Thrombolysis with an Escherichia coli-produced recombinant plasminogen activator (BM 06.022) in the rabbit model of jugular vein thrombosis. Thromb Haemostas 1991; 65: 560-564.
24. Sakharov D V, Domogatsky S P, Bos R, Rijken D C. An experimental system for investigation of penetration of components of the fibrinolytic system into a plasma clot. Fibrinolysis 1994; 8: 116-119.